Free Trial

Anteris Technologies Global (AVR) Stock Price, News & Analysis

Anteris Technologies Global logo
$6.77 +0.14 (+2.11%)
Closing price 04:00 PM Eastern
Extended Trading
$6.80 +0.03 (+0.37%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Anteris Technologies Global Stock (NASDAQ:AVR)

Advanced

Key Stats

Today's Range
$6.64
▼
$6.90
50-Day Range
$6.63
▼
$9.83
52-Week Range
$3.30
▼
$11.06
Volume
1.34 million shs
Average Volume
1.18 million shs
Market Capitalization
$659.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00
Consensus Rating
Hold

Company Overview

Anteris Technologies Global is a clinical-stage structural heart company developing technologies intended to treat aortic valve disease. The company’s lead product is the DurAVR transcatheter heart valve, which is designed to replicate the performance characteristics of a healthy human aortic valve and restore more natural blood flow.

Anteris uses its proprietary ADAPT tissue-engineering technology to create heart-valve materials designed for durability and biocompatibility. The company is focused primarily on transcatheter aortic valve replacement and related structural-heart applications, with its products progressing through clinical development and regulatory evaluation rather than broad commercial distribution.

The company has Australian origins and maintains operations and clinical-development activities in both Australia and the United States. Anteris Technologies Global is led by Chief Executive Officer Wayne Patmore and trades on the Nasdaq under the symbol AVR.

AI Generated. May Contain Errors.

Anteris Technologies Global Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
57th Percentile Overall Score

AVR MarketRank™: 

Anteris Technologies Global scored higher than 57% of companies evaluated by MarketBeat, and ranked 294th out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Anteris Technologies Global has received a consensus rating of Hold. The company's average rating score is 2.40, and is based on no strong buy ratings, 3 buy ratings, 1 hold rating, and 1 sell rating.

  • Upside Potential

    Anteris Technologies Global has a consensus price target of $14.00, representing about 106.8% upside from its current price of $6.77.

  • Amount of Analyst Coverage

    Anteris Technologies Global has only been the subject of 3 research reports in the past 90 days.

  • Read more about Anteris Technologies Global's stock forecast and price target.
  • Earnings Growth

    Earnings for Anteris Technologies Global are expected to grow in the coming year, from ($1.21) to ($0.96) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Anteris Technologies Global is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Anteris Technologies Global is -3.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Anteris Technologies Global's valuation and earnings.
  • Percentage of Shares Shorted

    7.17% of the float of Anteris Technologies Global has been sold short.
  • Short Interest Ratio / Days to Cover

    Anteris Technologies Global has a short interest ratio ("days to cover") of 7.65.
  • Change versus previous month

    Short interest in Anteris Technologies Global has recently increased by 3.90%, indicating that investor sentiment is decreasing.
  • Dividend Yield

    Anteris Technologies Global does not currently pay a dividend.

  • Dividend Growth

    Anteris Technologies Global does not have a long track record of dividend growth.

  • News Sentiment

    Anteris Technologies Global has a news sentiment score of 0.92. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 26 news articles for Anteris Technologies Global this week, compared to 4 articles on an average week.
  • Search Interest

    Only 1 people have searched for AVR on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
  • MarketBeat Follows

    2 people have added Anteris Technologies Global to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Anteris Technologies Global insiders have sold 115.86% more of their company's stock than they have bought. Specifically, they have bought $11,694,513.00 in company stock and sold $25,243,576.00 in company stock.

  • Percentage Held by Insiders

    4.50% of the stock of Anteris Technologies Global is held by insiders.

  • Percentage Held by Institutions

    Anteris Technologies Global has minimal institutional ownership at this time.

  • Read more about Anteris Technologies Global's insider trading history.
Receive AVR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Anteris Technologies Global and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVR Stock News Headlines

Anteris (NASDAQ: AVR) investor L1 Capital adds shares to its stake
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
Barclays Upgrades Anteris Technologies Global (NASDAQ:AVR) to "Hold"
See More Headlines

AVR Stock Analysis - Frequently Asked Questions

Anteris Technologies Global's stock was trading at $4.99 on January 1st, 2026. Since then, AVR stock has increased by 35.7% and is now trading at $6.77.

Anteris Technologies Global Corp. (NASDAQ:AVR) issued its earnings results on Tuesday, August, 11th. The company reported ($0.30) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.21) by $0.09. The company had revenue of $1.01 million for the quarter, compared to analyst estimates of $1.50 million. Anteris Technologies Global had a negative trailing twelve-month return on equity of 77.69% and a negative net margin of 4,619.27%.

Anteris Technologies Global (AVR) raised $100 million in an initial public offering (IPO) on Friday, December 13th 2024. The company issued 14,800,000 shares at a price of $6.78 per share.

Anteris Technologies Global's top institutional investors include Farther Finance Advisors LLC (0.02%). Insiders that own company stock include L1 Capital Pty Ltd and Susan Elizabeth Knight.
View institutional ownership trends
.

Shares of AVR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/11/2026
Today
10/09/2026
Next Earnings (Estimated)
11/11/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
NASDAQ:AVR
Previous Symbol
NASDAQ:AVR
CIK
2011514
Fax
N/A
Employees
174
Year Founded
2024

Price Target and Rating

High Price Target
$16.00
Low Price Target
$10.00
Potential Upside/Downside
+106.8%
Consensus Rating
Hold
Rating Score (0-4)
2.40
Research Coverage
5 Analysts

Profitability

EPS (Trailing Twelve Months)
($1.95)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$94.14 million
Net Margins
-4,619.27%
Pretax Margin
-4,568.02%
Return on Equity
-77.69%
Return on Assets
-67.99%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
14.20
Quick Ratio
14.20

Sales & Book Value

Annual Sales
$1.91 million
Price / Sales
345.45
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.01) per share
Price / Book
-677.00

Miscellaneous

Outstanding Shares
97,460,000
Free Float
93,072,000
Market Cap
$659.80 million
Optionable
N/A
Beta
1.87
7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report

This page (NASDAQ:AVR) was last updated on 10/9/2026 by MarketBeat.com Staff.
From Our Partners